Start-up Of Singapore Cancer Diagnostics Received 77 Million Usd Funding
Start-up (start-up) Biotechnology Mirxes Pte in Singapore has mobilized $ 77 million from investors led by CR-CP Life Science funds. CR-CP Life Science is a joint venture between China Resources Group and Thailand Group Charoen Pokphand Group. The company also said that other investors participated in Series C Calls including Rock Springs Capital, Edbi, CCB International Holdings and Keytone Ventures. According to an anonymous source, the capital call has raised the total amount mobilized so far to $ 120 million, bringing this 7-year-old Start-Up $ 500 million.Mirxes will use new capital flows to Speeding up plans to provide non-invasive screening tests, with the target of early detection of 6 common cancers